共 84 条
[1]
Castagno D(2012)Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (candesartan in heart failure: assessment of reduction in mortality and morbidity) program J Am Coll Cardiol 59 1785-1795
[2]
Skali H(2013)The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (efficacy of vasopressin antagonism in heart failure: outcome Study With Tolvaptan) trial JACC Heart Fail. 1 488-496
[3]
Takeuchi M(2008)botB. Heart rate as a prognostic risk factor in patients with coronary artery disease and leftventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Lancet. 372 817-821
[4]
Swedberg K(2001)Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program Am Heart J 142 498-501
[5]
Yusuf S(1997)Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group J Am Coll Cardiol. 29 1060-1066
[6]
Granger CB(2010)Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 875-885
[7]
Greene SJ(2006)Funny channels in the control of cardiac rhythm and mode of action of selective blockers Pharmacol Res 53 399-406
[8]
Vaduganathan M(2004)Multidisciplinary strategies for the management of heart failure patients at high risk for admission a systematic review of randomized trials J Am Coll Cardiol 44 810-819
[9]
Wilcox JE(2016)The Canadian cardiovascular society heart failure companion: bridging guidelines to your practice Can J Cardiol. 32 296-310
[10]
Harinstein ME(2001)ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 38 2101-2113